Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 59, Issue 3, 2000, Pages 190-195

  Berner, Beate ^a   Wolf, Gabriele ^a   Hummel, Klaus M ^a   Müller, Gerhard A ^a   Reuss Borst, Monika A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; AGED; ARTICLE; DENDRITIC CELL; DISEASE ACTIVITY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LIGAND BINDING; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REMISSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS;

EID: 0034072014     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.3.190     Document Type: Article

References (33)

1. 1 Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein signal for an activated helper T cells binds CD40 and transduces the signal for cognate activation of B cell. Proc Natl Acad Sci 1992;89:6550-4.
2. 2 Gravestein LA, Borst J. Tumor necrosis factor receptor family members in the immune system. Semin Immunol 1998; 10:423-34.
3. 3 Vogel LA, Noelle RJ. CD40 and its crucial role as a member of the TNFR family. Semin Immunol 1998;10:435-42.
4. 4 Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998;16:111-35.
5. 5 Clark LB, Foy TM, Noelle RJ. CD40 and its ligand. Adv Immunol 1996;63:43-78.
6. 6 Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993;14:559-64.
7. 7 Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063-73.
8. 8 Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996;98:826-37.
9. 9 Mohan C, Shi Y, Laman JD, Datta SK. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 1995;154:1470-80.
10. 10 Early GS, Zhao W, Burns CM. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response. J Immunol 1996;157:3159-64.
11. 11 Datta SK, Kalled SL. CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997;40:1735-45.
12. 12 Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum 1997;40:598-609.
13. 13 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. 14 Pinals RS, Baum J, Bland J, Fosdick WM, Kaplan SB, Masi AT, et al. Preliminary criteria for clinical remission in rheumatoid arthritis. Bull Rheum Dis 1982;32:7-10.
15. 15 Hsu YM, Lucci J, Su L, Ehrenfels B, Garber E, Thomas D. Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes. J Biol Chem 1997;272:911-15.
16. 16 Karpusas M, Hsu YM, Wang JH, Thompson J, Lederman S, Chess L, Thomas D. A crystal structure of an extracellular fragment of human CD40 ligand. Structure 1995;3: 1031-9.
17. 17 Müller B, Gimsa U, Mitchison NA, Radbruch A, Sieper J, Yin Z. Modulating the Th1/Th2 balance in inflammatory arthritis. Springer Semin Immunpathol 1998;20:181-96.
18. 18 Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, et al. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) upregulation and IL-6 production and proliferation. J Leukoc Biol 1995; 58:209-16.
19. 19 Harigai M, Hara M, Nakazawa S, Fukasawa C, Ohta S, Sugiura T, et al. Ligation of CD40 induced tumor necrosis factor-alpha in rheumatoid arthritis: a novel mechanism of activation of synoviocytes. J Rheumatol 1999;26:1035-43.
20. 20 MacDonald KP, Nishioka Y, Lipsky PE, Thomas R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997;100:2404-14.
21. 21 Afeltra A, Galeazzi M, Sebastiani GD, Ferri GM, Caccavo D, Addessi MA, et al. Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three-colour cytometric analysis. Int J Exp Pathol 1997;78:331-6.
22. 22 Hovdenes J, Gaudernack G, Kvien TK, Egeland T. Expression of activation markers on CD4+ and CD8+ cells from synovial fluid, synovial tissue, and peripheral blood of patients with inflammatory arthritides. Scand J Immunol 1989;29:631-9.
23. 23 Maurer D, Felzmann T, Holter W, Petera P, Smolen J, Knapp W. Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol 1992;87:429-34.
24. 24 Ichikawa Y, Shimizu H, Yoshida M, Arimori S. Activation antigens expressed on T-cells of the peripheral blood in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Rheumatol 1990;8:243-9.
25. 25 Kansas GS, Wood GS, Tedder TF. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol 1991;146:2235-44.
26. 26 Maliszewski CR, Delespesse GJ, Schoenborn MA, Armitage RJ, Fanslow WC, Nakajima T, et al. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 1994;153:3574-83.
27. 27 Wang TF, Guidotti G. CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J Biol Chem 1996;271:9898-901.
28. 28 Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7-CD28-T cells are expanded in rheumatoid arthritis and characterized by autoreactivity. J Clin Invest 1996;97:2027-37.
29. 29 Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997;40:1106-14.
30. 30 Namekawa T, Wagner UG, Goronzy JJ, Weyand CM. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 1998;41:2108-16.
31. 31 Lens SMA, Tesselaar K, van Oers MHJ, van Lier RAW. Control of lymphocyte function through CD27-CD70 interactions. Semin Immunol 1998;10:491-9.
32. don, CD27-memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 1996;39:844-54.
33. 33 Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand of CD40. Science 1993;261: 1328-30.